NO20022811L - Benzosyreestere av oksazolidinoner med en hydroksyacetylpiperazinsubstituent - Google Patents

Benzosyreestere av oksazolidinoner med en hydroksyacetylpiperazinsubstituent

Info

Publication number
NO20022811L
NO20022811L NO20022811A NO20022811A NO20022811L NO 20022811 L NO20022811 L NO 20022811L NO 20022811 A NO20022811 A NO 20022811A NO 20022811 A NO20022811 A NO 20022811A NO 20022811 L NO20022811 L NO 20022811L
Authority
NO
Norway
Prior art keywords
oxazolidinones
benzoic acid
acid esters
hydroxyacetylpiperazine
substituent
Prior art date
Application number
NO20022811A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022811D0 (no
Inventor
Jr Jackson B Hester
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20022811D0 publication Critical patent/NO20022811D0/no
Publication of NO20022811L publication Critical patent/NO20022811L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20022811A 1999-12-14 2002-06-13 Benzosyreestere av oksazolidinoner med en hydroksyacetylpiperazinsubstituent NO20022811L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17067599P 1999-12-14 1999-12-14
PCT/US2000/032432 WO2001044212A1 (en) 1999-12-14 2000-12-06 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent

Publications (2)

Publication Number Publication Date
NO20022811D0 NO20022811D0 (no) 2002-06-13
NO20022811L true NO20022811L (no) 2002-06-13

Family

ID=22620832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022811A NO20022811L (no) 1999-12-14 2002-06-13 Benzosyreestere av oksazolidinoner med en hydroksyacetylpiperazinsubstituent

Country Status (26)

Country Link
US (1) US6281210B1 (de)
EP (1) EP1242395B1 (de)
JP (1) JP2003516977A (de)
KR (1) KR20020062332A (de)
CN (1) CN1390211A (de)
AR (1) AR026547A1 (de)
AT (1) ATE288423T1 (de)
AU (1) AU1805801A (de)
BR (1) BR0015177A (de)
CA (1) CA2387047A1 (de)
CO (1) CO5261527A1 (de)
CZ (1) CZ20022389A3 (de)
DE (1) DE60017941T2 (de)
EA (1) EA200200673A1 (de)
ES (1) ES2236006T3 (de)
HU (1) HUP0203787A3 (de)
IL (1) IL150031A0 (de)
MX (1) MXPA02005909A (de)
NO (1) NO20022811L (de)
PE (1) PE20010851A1 (de)
PL (1) PL355369A1 (de)
PT (1) PT1242395E (de)
SK (1) SK5972002A3 (de)
TW (1) TW544449B (de)
WO (1) WO2001044212A1 (de)
ZA (1) ZA200202953B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
ATE321024T1 (de) * 2000-10-17 2006-04-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonverbindungen
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
ATE344036T1 (de) * 2002-11-21 2006-11-15 Pharmacia & Upjohn Co Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (de) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prophylaxe und Behandlung von thrombolischen Erkrankungen
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
WO2007039132A1 (de) 2005-10-04 2007-04-12 Bayer Healthcare Ag Neue polymorphe form und die amorphe form von 5-chlor-n- ( { ( 5s ) -2-0x0-3-[4-( 3-oxo-4-morpholinyl) - phenyl] -1,3-oxazolidin-5-yl} -methyl) -2- thiophencarboxamid
US20100210602A1 (en) * 2006-12-12 2010-08-19 The Johns Hopkins University PhoU (PerF), A PERSISTENCE SWITCH INVOLVED IN PERSISTER FORMATION AND TOLERANCE TO MULTIPLE ANTIBIOTICS AND STRESSES AS A DRUG TARGET FOR PERSISTER BACTERIA
WO2009001192A2 (en) * 2007-06-22 2008-12-31 Orchid Research Laboratories Limited Novel compounds and their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ274966A (en) * 1993-11-22 1998-01-26 Upjohn Co Substituted-hydroxyacetyl piperazine phenyl oxazolidinone derivatives, use in pharmaceutical compositions
MY116093A (en) * 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
FI19992555A7 (fi) * 1997-05-30 1999-11-30 Upjohn Co Antibakteerisia oksatosolidinoniaineita, joilla on tiokarbonyylifunktionaalisuus
GB9812019D0 (en) * 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
AU1805801A (en) 2001-06-25
AR026547A1 (es) 2003-02-19
ES2236006T3 (es) 2005-07-16
PE20010851A1 (es) 2001-08-17
WO2001044212A1 (en) 2001-06-21
EP1242395A1 (de) 2002-09-25
ATE288423T1 (de) 2005-02-15
US6281210B1 (en) 2001-08-28
IL150031A0 (en) 2002-12-01
SK5972002A3 (en) 2003-01-09
CO5261527A1 (es) 2003-03-31
KR20020062332A (ko) 2002-07-25
PL355369A1 (en) 2004-04-19
MXPA02005909A (es) 2002-10-23
CZ20022389A3 (cs) 2002-10-16
CA2387047A1 (en) 2001-06-21
TW544449B (en) 2003-08-01
BR0015177A (pt) 2002-06-18
DE60017941D1 (de) 2005-03-10
CN1390211A (zh) 2003-01-08
NO20022811D0 (no) 2002-06-13
PT1242395E (pt) 2005-05-31
EP1242395B1 (de) 2005-02-02
HUP0203787A2 (hu) 2003-07-28
HUP0203787A3 (en) 2005-06-28
EA200200673A1 (ru) 2002-12-26
DE60017941T2 (de) 2006-03-30
JP2003516977A (ja) 2003-05-20
ZA200202953B (en) 2003-09-23

Similar Documents

Publication Publication Date Title
EA200200699A1 (ru) Оксазолидиноны, обладающие сульфоксиминовой функциональностью
DK1322648T3 (da) 3-(heteroarylacetamido)-2-oxo-azetidin-1-sulfonsyrederivater som antibakterielle midler
NO931695L (no) Nye 4-arylpiperaciner og 4-arylpiperidiner
TR200001330T2 (tr) Oksazolidinon türevleri ve farmasötik terkipler
TR200402157T2 (tr) Heteroaril süksinamidler ve metalloproteinaz inhibitörü olarak kullanımları
DE69809187D1 (de) Metalloproteinase-Inhibitoren
ATE247972T1 (de) Pulmonare abgabe von protonierter/angesäuerter nukleinsäure
NO20002440L (no) Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
AR024158A1 (es) Compuestos antibacterianos
EG25017A (en) N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials.
DE602004004808D1 (de) Acyloxymethylcarbamat-prodrugs von oxazolidinonen
NO20014925L (no) Farmasöytiske forbindelser
BR0015177A (pt) ésteres de ácido benzóico de oxazolidinonas possuindo um substituinte hidroxiacetilpiperazina
NO20015669L (no) Heterocykliske substituerte aminoazacykler nyttige som sentralnervesystemmidler
NO20001169L (no) 6,9-bro erythromycinderivater
NO20035791L (no) Nye derivater av oksazolidinoner som antibakterielle midler
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
DE69615155D1 (de) Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
DE69600244D1 (de) Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
ATE155127T1 (de) Benzamid-derivate
BR0013751A (pt) Processo para produção de derivados de ácido naftiridina-3-carboxìlico
ATE140460T1 (de) Echinocandin-b-derivat
ES8504203A1 (es) Un procedimiento para preparar derivados de penem.
DE60004377D1 (de) Oral wirksame 7-alpha-alkyl androgene
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application